Desmopressin Acetate Injection, Solution
Product Images NDC 25021-461

2 FDA label images from Sagent Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Desmopressin Acetate (NDC 25021-461). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Des05 0005 01)

Figure (Des05 0005 01)
Chemical structure diagram showing the peptide sequence of desmopressin acetate with amino acid residues labeled and additional chemical groups (CH3COOH and 3H2O) indicated, representing the active ingredient desmopressin acetate.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Des05 0005 02)

Package Label – Principal Display Panel – Vial Label (Des05 0005 02)
Desmopressin Acetate Injection, USP 40 mcg per 10 mL (4 mcg per mL) sterile, nonpyrogenic multi-dose vial label. The injection solution is for intravenous or subcutaneous use only and labeled by Sagent Pharmaceuticals. Storage instructions specify keeping between 2 °C and 8 °C (36 °F and 46 °F). The label includes NDC 25021-461-10 and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.